Ernexa Therapeutics Inc. Finite-Lived Intangible Assets, Net
Ernexa Therapeutics Inc. (ERNA) had Finite-Lived Intangible Assets, Net of $696.00 thousand as of 2019-12-31, per its 10-K filed 2020-03-19.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2020-03-19
- 2019-12-31: Finite-Lived Intangible Assets, Net $696.00K.
- 2018-12-31: Finite-Lived Intangible Assets, Net $667.00K.
- 2017-12-31: Finite-Lived Intangible Assets, Net $1.00M.
- 2017-06-30: Finite-Lived Intangible Assets, Net $4.00K.
| Period end | Finite-Lived Intangible Assets, Net |
|---|---|
| 2019-12-31 | $696.00K 10-K · filed 2020-03-19 |
| 2018-12-31 | $667.00K 10-K · filed 2020-03-19 |
| 2017-12-31 | $1.00M 10-K · filed 2019-03-22 |
| 2017-06-30 | $4.00K 10-Q · filed 2017-08-04 |
| 2017-03-31 | $17.00K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $29.00K 10-K · filed 2018-03-09 |
| 2016-09-30 | $42.00K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $54.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $67.00K 10-Q · filed 2016-05-09 |
| 2015-12-31 | $79.00K 10-K · filed 2017-03-09 |
| 2015-09-30 | $92.00K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $104.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $117.00K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $129.00K 10-K · filed 2016-03-15 |
| 2014-09-30 | $154.00K 10-Q · filed 2014-11-07 |
| 2014-06-30 | $48.00K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $95.00K 10-Q · filed 2014-05-15 |
| 2013-12-31 | $160.00K 10-K · filed 2015-03-27 |
| 2013-09-30 | $259.00K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $363.00K 10-Q · filed 2013-08-14 |
| 2013-03-31 | $468.00K 10-Q · filed 2013-05-13 |
| 2012-12-31 | $579.00K 10-K · filed 2014-03-31 |
| 2012-09-30 | $567.00K 10-Q · filed 2012-11-09 |
| 2012-06-30 | $658.00K 10-Q · filed 2012-08-14 |
| 2012-03-31 | $753.00K 10-Q · filed 2012-05-11 |
| 2011-12-31 | $845.00K 10-K · filed 2013-03-29 |
| 2011-09-30 | $720.00K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $827.00K 10-Q · filed 2011-08-12 |
| 2010-12-31 | $1.02M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |